Micrometastatic disease in breast cancer : Clinical implicationsIGNATIADIS, Michail; GEORGOULIAS, Vassilis; MAVROUDIS, Dimitris et al.European journal of cancer (1990). 2008, Vol 44, Num 18, pp 2726-2736, issn 0959-8049, 11 p.Article

Phase III Study Comparing Sequential Versus Alternate Administration of Cisplatin-Etoposide and Topotecan as First-line Treatment in Small Cell Lung CancerBAKA, Sophia; AGELAKI, Sophia; ANDROULAKIS, Nikolaos et al.Anticancer research. 2010, Vol 30, Num 7, pp 3031-3038, issn 0250-7005, 8 p.Article

Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel―mediated anti-tumor effectSPILIOTAKI, Maria; MARKOMANOLAKI, Haris; MELA, Marilena et al.Lung cancer. 2011, Vol 73, Num 2, pp 158-165, issn 0169-5002, 8 p.Article

Fulvestrant in the treatment of advanced breast cancer: A systematic review and meta-analysis of randomized controlled trialsVALACHIS, Antonis; MAURI, Davide; POLYZOS, Nikolaos P et al.Critical reviews in oncology/hematology. 2010, Vol 73, Num 3, pp 220-227, issn 1040-8428, 8 p.Article

Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapyVASSALOU, Helen; STATHOPOULOS, Efstathios; FIOLITAKI, Georgia et al.Lung cancer. 2013, Vol 82, Num 2, pp 324-329, issn 0169-5002, 6 p.Article

Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinibKALYKAKI, Antonia; AGELAKI, Sofia; KALLERGI, Galatea et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 4, pp 685-693, issn 0344-5704, 9 p.Article

Prognostic Significance of the Detection of Peripheral Blood CEACAM5mRNA-Positive Cells by Real-Time Polymerase Chain Reaction in Operable Colorectal CancerVARDAKIS, Nikolaos; MESSARITAKIS, Ippokratis; MAVROUDIS, Dimitris et al.Clinical cancer research (Print). 2011, Vol 17, Num 1, pp 165-173, issn 1078-0432, 9 p.Article

Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancerKIOULAFA, Magdalini; BALKOURANIDOU, Ioanna; SOTIROPOULOU, Georgia et al.International journal of cancer (Print). 2009, Vol 125, Num 12, pp 2887-2892, issn 0020-7136, 6 p.Article

Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapseGIATROMANOLAKI, Alexandra; KOUKOURAKIS, Michael I; KAKOLYRIS, Stelios et al.International journal of cancer. 2004, Vol 108, Num 4, pp 620-627, issn 0020-7136, 8 p.Article

A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancerSARIDAKI, Zacharenia; MALAMOS, Nikolaos; KOURAKOS, Panagiotis et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 35-42, issn 0344-5704, 8 p.Article

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)BOUKOVINAS, Ioannis; ANDROULAKIS, Nikolaos; KOSTAKOPOULOS, Athanasios et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 2, pp 351-356, issn 0344-5704, 6 p.Article

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancerKOTSAKIS, Athanasios; AGELAKI, Sophia; GEORGOULIAS, Vassilis et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 2, pp 415-422, issn 0344-5704, 8 p.Article

Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumabPOLYZOS, Aris; KALBAKIS, Kostas; MAVROUDIS, Dimitris et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 1, pp 217-223, issn 0344-5704, 7 p.Article

Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptideBOLONAKI, Irini; KOTSAKIS, Athanassios; CORDOPATIS, Paul et al.Journal of clinical oncology. 2007, Vol 25, Num 19, pp 2727-2734, issn 0732-183X, 8 p.Article

Second-line chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trialKATOPODIS, Ourania; POLYZOS, Aris; KENTEPOZIDIS, Nikolaos et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 361-368, issn 0344-5704, 8 p.Article

Sequential Administration of the Native TERT₅₇₂ Cryptic Peptide Enhances the Immune Response Initiated by its Optimized Variant TERT_572Y in Cancer PatientsVETSIKA, Eleni-Kyriaki; PAPADIMITRAKI, Elisavet; CHRISTOPHYLLAKIS, Charalampos et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 9, pp 641-650, issn 1524-9557, 10 p.Article

Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosisGIOULBASANIS, Ioannis; GEORGOULIAS, Panagiotis; VLACHOSTERGIOS, Panagiotis J et al.Lung cancer. 2011, Vol 74, Num 3, pp 516-520, issn 0169-5002, 5 p.Article

A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumorsSARIDAKI, Zacharenia; PAPPAS, Periklis; SOUGLAKOS, John et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 121-128, issn 0344-5704, 8 p.Article

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation statusKALIKAKI, Aristea; KOUTSOPOULOS, Anastasios; HATZIDAKI, Dora et al.Lung cancer. 2010, Vol 69, Num 1, pp 110-115, issn 0169-5002, 6 p.Article

A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancerBOZIONELOU, Vasiliki; KALBAKIS, Kostas; VAMVAKAS, Lambros et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 4, pp 785-791, issn 0344-5704, 7 p.Article

Gefitinib in Combination with Gemcitabine and Vinorelbine in Patients with Metastatic Breast Cancer Pre-treated with Taxane and Anthracycline Chemotherapy : A Phase I/II TrialGIOULBASANIS, Ioannis; SARIDAKI, Zacharenia; KALYKAKI, Antonia et al.Anticancer research. 2008, Vol 28, Num 5B, pp 3019-3025, issn 0250-7005, 7 p.Article

Gemcitabine plus Oxaliplatin (GEMOX) in Pretreated Patients with Advanced Ovarian Cancer : A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)KALYKAU, Antonia; PAPAKOTOULAS, Pavlos; MAVROUDIS, Dimitris et al.Anticancer research. 2008, Vol 28, Num 1B, pp 495-500, issn 0250-7005, 6 p.Article

Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas : Correlation with clinical outcomeKOUTSOPOULOS, Anastassios V; MAVROUDIS, Dimitris; DAMBAKI, Konstantina I et al.Lung cancer. 2007, Vol 57, Num 2, pp 193-200, issn 0169-5002, 8 p.Article

Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized Phase 3 StudyKARAMPEAZIS, Athanasios; VOUTSINA, Alexandra; AGELAKI, Sofia et al.Cancer. 2013, Vol 119, Num 15, pp 2754-2764, issn 0008-543X, 11 p.Article

Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001VETSIKA, Eleni-Kyriaki; KONSOLAKIS, Georgios; AGGOURAKI, Despoina et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 2, pp 157-168, issn 0340-7004, 12 p.Article